DMD-AS3

Across TCGA pan-cancer cohorts, DMD-AS3 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated DMD-AS3 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher DMD-AS3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated DMD-AS3 expression acts as an unfavorable survival marker.

BLCA and KIRC are the cancer types where DMD-AS3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.213	0.722	<.001	126	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

DMD-AS3–BLCA (OS)

Open the BLCA breakdown →